NR prevents and reverts NAFLD by inducing a SIRT1- and SIRT3-dependent mitochondrial unfolded protein response, triggering an adaptive mitohormetic pathway to increase hepatic β-oxidation and mitochondrial complex content 29,32. The gene discussed is SIRT3; the disease is metabolic dysfunction-associated steatotic liver disease.